✦ LIBER ✦

A phase II, randomized, blinded study of the farnesyltransferase inhibitor tipifarnib combined with letrozole in the treatment of advanced breast cancer after antiestrogen therapy

✍ Scribed by Stephen R. D. Johnston; Vladimir F. Semiglazov; George M. Manikhas; Dominique Spaeth; Gilles Romieu; David J. Dodwell; Andrew M. Wardley; Patrick Neven; Annick Bessems; Youn C. Park; Peter M. De Porre; Juan J. Perez Ruixo; Angela J. Howes

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 180 KB
Volume: 110
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-007-9726-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized phase II study of PX-12, an

A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination

✍ Ramesh K. Ramanathan; James Abbruzzese; Tomislav Dragovich; Lynn Kirkpatrick; Jo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 267 KB

The use of antiestrogens tamoxifen and n

The use of antiestrogens tamoxifen and nafoxidine in the treatment of human breast cancer in correlation with estrogen receptor values. A phase II study

✍ Dane L. Moseson; Gordon H. Sasaki; William G. Kraybill; Benjamin S. Leung; Charl 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB 👁 2 views

A phase II study of combination therapy

A phase II study of combination therapy with 5′-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci

✍ Wasaburo Koizumi; Minoru Kurihara; Tadashi Sasai; Shigeaki Yoshida; Kimitomo Mor 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

Background. 5'-Deoxy-5-fluorouridine (5'-DFUR, doxifluridine) is a recently developed prodrug of oral From the Japan Gastric Cancer Study Group,

A randomized, phase II, dose-finding stu

A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer

✍ Olivier Rixe; Sandra X. Franco; Denise A. Yardley; Stephen R. Johnston; Miguel M 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 367 KB

Aminoglutethimide and medroxyprogesteron

Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer: A phase II study of the association of medical oncology of the German cancer society (AIO)

✍ Hans-Erik Wander; Gerd Arno Nagel; Hans-Christian Blossey; Ulrich Kleeberg 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

Pegylated liposomal doxorubicin in combi

Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study

✍ Alexandros Ardavanis; Dimitris Mavroudis; Kostas Kalbakis; Nikolaos Malamos; Kos 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 292 KB